ESC 365 - Hemodynamic and clinical effects of ARNI therapy in patients with advanced heart failure undergoing repeated Levosimendan infusions

HFA Premium Access

Hemodynamic and clinical effects of ARNI therapy in patients with advanced heart failure undergoing repeated Levosimendan infusions

Session: Poster Session 2 - Chronic Heart Failure – Treatment

Topic: Treatment

Event: Heart Failure 2019

Congress Presentation

55 more presentations in this session

Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration

Speaker: Doctor A. Ntalianis (Athens, GR)

Prescription of sacubitril/valsartan in a real-world population

Speaker: Mr J. AGOSTINHO (Lisbon, PT)

Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience

Speaker: Doctor F. Ferreira (Lisbon, PT)

The dangers of non-heart failure hospitalisation for heart failure patients: frequent medication changes without follow up

Speaker: Ms E. O'Donoghue (Dublin, IE)

Clinical, echocardiographic and cost improvement after the onset with sacubitril-valsartan in mexican patients with heart failure.

Speaker: Doctor V. Gomez Leiva (San Salvador, SV)

Access the full session

Poster Session 2 - Chronic Heart Failure – Treatment

Speakers: Doctor A. Ntalianis, Mr J. AGOSTINHO, Doctor F. Ferreira, Ms E. O'Donoghue, Doctor V. Gomez Leiva

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by